Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MORF - Morphic: Pioneering Integrin Medicines

MORF - Morphic: Pioneering Integrin Medicines

Morphic Holding Inc.
  • Morphic is pursuing a multi-billion opportunity of replacing biologics modulating integrins with small molecules.
  • The company is founded by the individual who discovered integrins and has built a unique technology platform to design selective oral therapies for integrins.
  • Morphic recently reported promising phase 1 data for its lead asset, MORF-057 establishing safety.
  • Now the company is bringing their lead asset into phase 2 trials; however, with the concentration risk and current valuation, Morphic is a stock worth monitoring as the trial progresses.

For further details see:

Morphic: Pioneering Integrin Medicines
Stock Information
Company Name: Morphic Holding Inc.
Stock Symbol: MORF
Market: NASDAQ
Website: morphictx.com
Menu
MORF MORF Quote MORF Short MORF News MORF Articles MORF Message Board
Get MORF Alerts

News, Short Squeeze, Breakout and More Instantly...